Target Price | $45.90 |
Price | $24.55 |
Potential |
86.97%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target IDEAYA Biosciences Inc 2026 .
The average IDEAYA Biosciences Inc target price is $45.90.
This is
86.97%
register free of charge
$67.20
173.73%
register free of charge
$25.25
2.85%
register free of charge
|
|
A rating was issued by 22 analysts: 19 Analysts recommend IDEAYA Biosciences Inc to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the IDEAYA Biosciences Inc stock has an average upside potential 2026 of
86.97%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 7.00 | 11.36 |
70.07% | 62.30% | |
EBITDA Margin | -4,637.00% | -2,817.65% |
721.97% | 39.24% | |
Net Margin | -3,921.14% | -2,664.58% |
711.93% | 32.05% |
18 Analysts have issued a sales forecast IDEAYA Biosciences Inc 2025 . The average IDEAYA Biosciences Inc sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an IDEAYA Biosciences Inc EBITDA forecast 2025. The average IDEAYA Biosciences Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
17 IDEAYA Biosciences Inc Analysts have issued a net profit forecast 2025. The average IDEAYA Biosciences Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -3.36 | -3.45 |
71.43% | 2.68% | |
P/E | negative | |
EV/Sales | 130.44 |
17 Analysts have issued a IDEAYA Biosciences Inc forecast for earnings per share. The average IDEAYA Biosciences Inc EPS is
This results in the following potential growth metrics and future valuations:
IDEAYA Biosciences Inc...
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Locked
➜
Locked
|
Locked | Jul 28 2025 |
TD Cowen |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jul 09 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jun 26 2025 |
JP Morgan |
Locked
➜
Locked
|
Locked | May 22 2025 |
Stephens & Co. |
Locked
➜
Locked
|
Locked | Feb 14 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jan 15 2025 |
Analyst Rating | Date |
---|---|
Locked
JP Morgan:
Locked
➜
Locked
|
Jul 28 2025 |
Locked
TD Cowen:
Locked
➜
Locked
|
Jul 22 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 09 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jun 26 2025 |
Locked
JP Morgan:
Locked
➜
Locked
|
May 22 2025 |
Locked
Stephens & Co.:
Locked
➜
Locked
|
Feb 14 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 15 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.